Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Suleyman Buyukberber"'
Autor:
Umut Demirci, Ahmet Alacacioglu, Faysal Dane, Mehmet Ali Kaplan, Gamze Goksel, Ahmet Siyar Ekinci, Ugur Coskun, Muharrem Kocar, Bulent Cetin, Efnan Algin, Mahmut Gumus, Ozan Yazici, Suleyman Buyukberber, Berna Oksuzoglu, Özlem Balvan Erceleb, Ayhan Yildiz, Ozge Gumusay, Mukremin Uysal, Veli Berk, Tulay Akman, Burcu Yapar Taskoylu, Ilhan Oztop
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 140:151-157
Background: The development of brain metastases (BMs) was associated with poor prognosis in melanoma patients. Patients with BMs have a median survival of 4 mm) (p = 0.008), ulceration (p = 0.007), and pathologically N2 and N3 diseases (p = 0.001) we
Autor:
Suleyman Buyukberber, Ozge Gumusay, Mustafa N. Ilhan, Mustafa Benekli, Ahmet Ozet, Basak Bostankolu, Gamze Gurcan, Ugur Coskun, Bulent Cetin, Aytug Uner
Cancer patients who start receiving chemotherapy have difficulty in understanding the state of their disease, the prognosis, and the purpose of treatment. We used a survey to evaluate the extent of perception of chemotherapy goal among cancer patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::844247a273926bc681d7c8740033e8ed
https://avesis.gazi.edu.tr/publication/details/4f8fa9f0-9a61-45e6-a447-8db6cdf83544/oai
https://avesis.gazi.edu.tr/publication/details/4f8fa9f0-9a61-45e6-a447-8db6cdf83544/oai
Autor:
Onder Tonyali, Mehmet Kucukoner, Halit Karaca, Suleyman Buyukberber, Mustafa Benekli, Ramazan Yildiz, Sinemis Yuksel, Ahmet Taner Sümbül, Berna Oksuzoglu, Arife Ulas, Asude Aksoy, Mevlude Inanc, Dogan Yazilitas, Yusuf Gunaydin, Mukremin Uysal, Tulay Akman, Ozgur Tanriverdi, Oznur Bal, Aydin Ciltas, Ugur Coskun, Umut Demirci
Purpose The aim of this study was to determine risk factors for brain metastasis as the first site of disease recurrence in patients with HER2-positive early-stage breast cancer (EBC) who received adjuvant trastuzumab. Methods Medical records of 588
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89bd70a1e160926214377e6377f52ed7
https://avesis.deu.edu.tr/publication/details/0971fb60-1f8a-44e3-a741-3e41d93e4af0/oai
https://avesis.deu.edu.tr/publication/details/0971fb60-1f8a-44e3-a741-3e41d93e4af0/oai
Autor:
Ozan Yazici, Nuriye Ozdemir, Ayse Ocak Duran, Serkan Menekse, Mehmet Ali, Nahit Sendur, Halit Karaca, Gamze Goksel, Erkan Arpaci, Hacıbekiroğlu, İlhan, Irem Bilgetekin, Turgut Kacan, Metin Ozkan, Sercan Aksoy, Asude Aksoy, Suna Cokmert, Uysal, Mehmet, Emin Tamer Elkiran, Irfan Cicin, Suleyman Buyukberber, Nurullah Zengin
WOS: 000368937200011
PubMed ID: 26775722
Aim: To investigate the role of surgical resection of primary tumor on overall survival (OS) in advanced gastric cancer patients at the time of diagnosis. Patients & methods: The survival rates of me
PubMed ID: 26775722
Aim: To investigate the role of surgical resection of primary tumor on overall survival (OS) in advanced gastric cancer patients at the time of diagnosis. Patients & methods: The survival rates of me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d9df49805a629d3da5f32587f84d242
https://hdl.handle.net/20.500.12619/71886
https://hdl.handle.net/20.500.12619/71886
Autor:
Mahmut Gumus, Aytug Uner, Nuriye Ozdemir, Ugur Coskun, Mevlude Inanc, Berna Oksuzoglu, Oznur Bal, Nur Sener, Umut Demirci, Mustafa Benekli, Deniz Yamac, Ramazan Yildiz, Suleyman Buyukberber, Halit Karaca, Dogan Yazilitas, Tulay Akman, Onder Tonyali, Olcun Umit Unal
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 138:2145-2151
Trastuzumab is known to be effective for early and advanced stages of breast cancer but optimal duration for early-stage breast cancer (EBC) is not well known. We evaluated the efficacy and toxicity of 9- and 52-week trastuzumab therapy for EBC retro
Autor:
Mustafa Benekli, Nurullah Zengin, Ugur Coskun, Suleyman Buyukberber, Meltem Baykara, Nalan Akgul Babacan, Bulent Cetin, Umut Demirci, Nuriye Ozdemir
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 13:383-386
Background: Cancer survivors are at increased risk of second cancers. Lymphoproliferative disorders (LPD) are common neoplasms that are primary or subsequent cancers in cases of multiple primary cancer. We here analyzed metachronous or synchronous LP
Autor:
Suleyman Buyukberber, Mustafa Benekli, Bulent Cetin, Ozge Gumusay, Guldal Yilmaz, Ugur Coskun, Efnan Algin, Meltem Baykara, Ramazan Yildiz, Ahmet Ozet
In this retrospective study, we aimed to evaluate the clinicopathological characteristics of the patients presenting with liver metastases from unknown primary site besides survival rates, treatment outcomes, and prognostic factors. In all, 68 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44883d120d407df73f4445dad8bfba5a
https://avesis.gazi.edu.tr/publication/details/f113c148-bfea-4ed7-aa30-17ff8ae7b76c/oai
https://avesis.gazi.edu.tr/publication/details/f113c148-bfea-4ed7-aa30-17ff8ae7b76c/oai
Autor:
Omur Berna Oksuzoglu, Nuriye Ozdemir, Cagatay Arslan, Ramazan Yildiz, Suleyman Buyukberber, Başak Bala Ustaalioğlu Öven, Ummugul Uyeturk, Nalan Akgul Babacan, M. K. Altundag, Ibrahim Turker, Muhammed Bulent Akinci, Muhammet Fuat Özcan, Burcin Budakoglu, Nurullah Zengin, Omer Dizdar, Sercan Aksoy
Publikováno v:
Medical Oncology. 29:1892-1895
Chronic infections with hepatitis C virus (HCV) are frequently pronounced in the etiology of malignancies especially in hepatocellular carcinoma. The association between HCV and risk of renal cell carcinoma (RCC) development has been stated recently.
Publikováno v:
International Immunopharmacology. 9:645-648
M30-Apoptosense and M65 ELISAs can detect caspase cleaved and intact forms of cytokeratin 18. As biologic marker of cell death, both assays can be useful to evaluate prognosis and chemotherapy response in the patients with breast, lung, and endometri
Autor:
Banu Ozturk, Diclehan Ünsal, A. Osman Kaya, Mustafa Benekli, Ramazan Yildiz, Emel Yaman, Huseyin Bora, Yücel Pak, Suleyman Buyukberber, Deniz Yamac, Aytug Uner, Müge Akmansu, Ugur Coskun
Publikováno v:
Medical Oncology. 25:269-273
The aim of the study was to evaluate the toxicity and efficacy of 62 patients with locally advanced nasopharyngeal carcinoma (NPC) (stage III, IVA, IVB) treated by three different modalities. Cisplatin was given weekly 35 mg/m(2)/day or every 3 weeks